Nexvet Biopharma Plc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/17 Q3

ended 12/31/16 Q2

ended 09/30/16 Q1

ended 06/30/16 FY 2016

ended 03/31/16 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Registration withdrawal request

Shelf registration – amended

Ownership Filter

Broadfin Capital, LLC

Farallon Capital Management LLC

Payne John Bernard

McCracken Joseph S

Lismore Damian T.

News Filter

Recommended Acquisition for Cash By

Companies Act 2014 a Public Company Limited by Shares Memorandum of Association of Nexvet Biopharma Public Limited Company

(“Nexvet”) Rule 2.10 Announcement

(“Nexvet”) Rule 2.10 Announcement

(“Nexvet”) Rule 15 Announcement

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC